pharma news today glp-1 2025 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 Pharma Giants Bet on Next-Generation

Open access peer-reviewed chapter

Citrucel with SmartFiber is proven to help restore and maintain regularity

GLP-1s, and mor medications, nutrition, exercise, genetic testing & body composition analysis.

GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for people with knee osteoarthritis and obesity, with tirzepatide providing greater health benefits at lower cost compared to semaglutide

Among these are the beta-cell hormone amylin and the intestinal L cell hormone glucagon-like peptide-1 (GLP-1)